Our Blog

As the FDA and HHS initiate a strategic review of the infant formula industry through Operation StorkSpeed, ObvioHealth’s experience in modernizing infant nutrition research offers a timely and relevant model for faster, safer, and more scalable clinical trials.

In response to rising healthcare demands, ObvioHealth is redefining clinical trials through decentralized models and patient-first technology that improves access, engagement, and data quality.

The FDA and OHRP have released new draft guidance providing recommendations for making the informed consent process as clear and comprehensive as possible for participants. Here's what you need to know.

Patient-reported outcomes are crucial components of every clinical trial—and they’re stronger and more accurate when captured electronically. Here’s what you need to know about PROs and ePROs.

AI, patient advocacy groups, digital health technologies, and more. Here’s everything you need to know about the clinical trial trends of 2024—and how they’re reshaping the industry.